Enzyme vs Neutron — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Neutron trades at Rp25.52 (market cap Rp78,1M, Rp76,5M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and Neutron's supply is capped (804,1M / 999,7M NTRN (81%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Neutron for 38 Days on average.
| MLN | NTRN | |
|---|---|---|
Market Cap | Rp134,13M | Rp78,1M |
Volume (24h) | Rp104,56M | Rp76,5M |
Circulating Supply | 3,3M MLN | 804,1M / 999,7M NTRN (81%) |
Typical Hold Time | 29 Days | 38 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Neutron (NTRN) shows limited market activity with a modest market cap of Rp78,1M and 81% circulating supply. The token exhibits minimal trading volume and network engagement, with no recent protocol updates or significant ecosystem developments. Technical indicators suggest low volatility and limited price movement due to thin liquidity.
Overall outlook remains cautious with major risks including extreme illiquidity, regulatory uncertainty, and lack of developer activity. Key opportunity exists only if the project gains meaningful adoption or exchange listings. Current holders face significant liquidity constraints with average hold time of 38 days.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Neutron is the most secure cross-chain smart-contracting platform. It combines the security of a top 10 blockchain by staked capitalization with bleeding-edge cross-chain infrastructure to enable DeFi applications to securely scale across a growing network of 51+ interconnected blockchains.
Read more on NTRN →